Biologics News

Under proposed new rules to enhance disclosure of financial conflict of interest by federally funded biomedical researchers and their institutions, the chief responsibility for disclosing significant and potentially conflicting financial interests would shift from individual investigators to their institutions, according to a Journal of the American Medical Association (JAMA) commentary written by Francis S. Collins, MD, PhD, director of the National Institutes of Health, and colleague Sally J. Rockey, PhD.

OSLO — Following Achilles tendon rupture there were no differences in patients treated with platelet-rich plasma and controls for the usual parameters used to assess such cases, however some of the control group’s outcomes exceeded those in the treated group, according to a randomized study performed by investigators from Linköping, Sweden.

OSLO — Patients selected to be enrolled in trials studying treatment of knee cartilage defects involve so select a group that Norwegian researchers wonder whether those studies’ finding should be applied to the average individual with a knee cartilage defect.

A study presented at the 57th Annual Meeting of the Society for Nuclear Medicine (SNM) indicates that using multiple imaging agents with a hybrid imaging technique can be a valuable tool for accurately diagnosing and determining treatment for a variety of diabetes-associated foot diseases.

MADRID — Autologous platelet-rich plasma has shown in an investigation to provide short-term patient satisfaction after its use in the treatment of severe Achilles tendinosis, according to a researcher, here.

MADRID — For the treatment of juvenile bone cysts, tricalcium phosphate application using a minimally invasive technique achieved statistically better results than methylprednisolone injection, according to orthopaedic investigators.

MADRID — Results from an investigation by investigators from Ireland has revealed risk factors for premenopausal women at risk for osteoporosis.

Platelet rich plasma has been shown to stimulate healing in various clinical situations. Spanish researchers, however, found from their experimental New Zealand White rabbit model that it did not perform well for healing critical bone defects.

Endothelial progenitor cells showed much better potential than mesenchymal stem cells for fracture healing and angiogenesis in a recent animal study.

by Anthony M. DiGioia III, MD; and John M. Tokish, MD